These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16183423

  • 1. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 3. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 4. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 5. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F, Rosenkranz AR, Burgmann H, Graninger W, Hollenstein U, Schenk P, Thalhammer-Scherrer R, Traindl O, Hörl WH, Breyer S.
    Wien Klin Wochenschr; 1997 May 23; 109(10):362-5. PubMed ID: 9200809
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug 23; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 7. [Vancomycin dosing in hemodialysis patients].
    Castellano I, González Castillo PM, Covarsí A, Martínez Sánchez J, Suárez Santisteban MA, Gallego S, Marigliano N.
    Nefrologia; 2008 Aug 23; 28(6):607-12. PubMed ID: 19016633
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G, Acuna V, Perez C, Labarca J, Guevara A, Tagle R.
    Int J Clin Pharmacol Ther; 1996 Feb 23; 34(2):71-5. PubMed ID: 8929749
    [Abstract] [Full Text] [Related]

  • 9. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA.
    Pharmacotherapy; 1997 Feb 23; 17(2):256-62. PubMed ID: 9085316
    [Abstract] [Full Text] [Related]

  • 10. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ, De Bacquer D, De Vriese AS.
    Clin Infect Dis; 2011 Jul 15; 53(2):124-9. PubMed ID: 21690618
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y, Hernández Castillo R, Santiago E, Ramírez Yuch N, Jaume Anselmi F, Jové R, Flores R, Lebrón R, Ramírez Rivera J.
    Bol Asoc Med P R; 2012 Jul 15; 104(3):10-4. PubMed ID: 23156886
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.
    Clin Pharmacol Ther; 2000 Sep 15; 68(3):238-49. PubMed ID: 11014405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE, King JH.
    Ann Pharmacother; 2006 Jan 15; 40(1):9-14. PubMed ID: 16332944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ, De Vriese AS.
    Semin Dial; 2011 Jan 15; 24(1):50-5. PubMed ID: 21338394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
    Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ.
    Am J Kidney Dis; 1995 Sep 15; 26(3):469-74. PubMed ID: 7645555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.